FDA-approved fatty liver drug also suppresses liver tumors in mice

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...
The New England Journal of Medicine

Case 9-2025: A 59-Year-Old Man with Hepatocellular Carcinoma

Dr. David M. Dudzinski: A 59-year-old man with a history of obesity, dyslipidemia, and hypertension was evaluated in the oncology clinic of this hospital because of hepatocellular carcinoma.
EurekAlert!

HKUMed discovers expanded use of fatty liver drug for preventing and suppressing liver cancer

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...
ascopubs.org

Ultra-sensitive detection of hepatocellular carcinoma (HCC) with methylation signal enrichment of ctDNA and hepatitis B virus (HBV).

Effect of the combination of systemic and locoregional therapy on tumor recurrence and survival after liver transplantation for hepatocellular carcinoma (HCC). This is an ASCO Meeting Abstract from ...